IRIS
MESSINA, Sonia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.765
EU - Europa 5.152
AS - Asia 2.033
SA - Sud America 22
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 2
Totale 12.999
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.726
IE - Irlanda 1.673
CN - Cina 1.065
SE - Svezia 981
SG - Singapore 773
IT - Italia 619
DE - Germania 455
PL - Polonia 422
UA - Ucraina 318
FI - Finlandia 299
GB - Regno Unito 180
IN - India 95
FR - Francia 85
BE - Belgio 40
VN - Vietnam 38
CA - Canada 24
BR - Brasile 18
NL - Olanda 18
ID - Indonesia 17
MX - Messico 14
CZ - Repubblica Ceca 13
RU - Federazione Russa 12
EU - Europa 11
AT - Austria 9
IR - Iran 9
HK - Hong Kong 7
NZ - Nuova Zelanda 7
AU - Australia 6
LT - Lituania 6
TR - Turchia 6
ES - Italia 5
KR - Corea 4
PT - Portogallo 4
PH - Filippine 3
PS - Palestinian Territory 3
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
HR - Croazia 2
NO - Norvegia 2
RO - Romania 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CH - Svizzera 1
IL - Israele 1
JP - Giappone 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
PA - Panama 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 12.999
Salva come PNG Salva come JPEG
Città #
Dublin 1.667
Chandler 1.064
Jacksonville 793
Singapore 618
Nyköping 571
Beijing 483
Warsaw 420
Princeton 365
Medford 308
Ashburn 281
Cambridge 261
Des Moines 215
Ann Arbor 212
Dearborn 182
Messina 161
Boardman 146
San Mateo 94
Lancaster 92
Shenyang 75
Wilmington 72
Jinan 71
Pune 70
Bremen 68
Rome 56
Nanjing 52
Woodbridge 44
New York 42
Los Angeles 40
Tianjin 39
Dong Ket 38
Brussels 37
Houston 37
Munich 33
Hebei 32
Ningbo 32
Zhengzhou 32
Hangzhou 30
Helsinki 24
Haikou 22
Taizhou 21
Nanchang 20
Lappeenranta 19
Norwalk 19
Guangzhou 18
Jakarta 17
Nürnberg 17
Seattle 16
Falls Church 15
Fuzhou 13
Palo Del Colle 13
Changsha 11
Jiaxing 11
Augusta 10
Catania 10
Milan 10
Taiyuan 10
Brno 9
Guadalupe 9
Leawood 9
Riposto 9
Toronto 9
Amsterdam 8
Hyderabad 8
Lanzhou 8
London 8
Ottawa 8
Bagheria 7
Fort Worth 7
Hong Kong 7
Tappahannock 7
Vienna 7
Ardabil 6
Auburn Hills 6
Paris 6
Washington 6
Ciudad Benito Juárez 5
Clearwater 5
Fairfield 5
Hanover 5
Monmouth Junction 5
Shanghai 5
Trecastagni 5
Auckland 4
Bari 4
Bergamo 4
Dallas 4
Mumbai 4
Padova 4
Prineville 4
Segrate 4
Wuhan 4
Bologna 3
Caserta 3
Glasgow 3
Hefei 3
Hemel Hempstead 3
Kanpur 3
Mannheim 3
Mountain View 3
Napoli 3
Totale 9.371
Salva come PNG Salva come JPEG
Nome #
Severe rhabdomyolysis in a patient with “Heat Stroke” 194
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 104
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 94
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy 92
Hippo signaling pathway is altered in Duchenne muscular dystrophy 87
The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability. 85
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 84
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 84
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 83
Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study. 81
A new form of alpha-dystroglycanopathy associated with severe drug-resistant epilepsy and unusual EEG features 81
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data 81
An observational study of functional abilities in infants, children, and adults with type 1 SMA 77
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 75
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 74
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 73
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 72
Histological effects of givinostat in boys with Duchenne muscular dystrophy 72
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 71
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 71
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 68
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 68
Effect of exercise on telomere length and telomere proteins expression in mdx mice 68
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice. 67
Pilot study of flavocoxid in ambulant DMD patients. 67
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues” 66
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 66
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 66
Muscle Fat-Fraction and Mapping in Duchenne Muscular Dystrophy: Evaluation of Disease Distribution and Correlation with Clinical Assessments: A preliminary experience. 65
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study 65
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 65
Pilot study of serial casting in muscular dystrophy patients. 64
The 24-month PUL changes and steroids correlation. 64
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 64
EFFECT OF TREATMENT WITH PDTC AND IRFI 042 ON STRENGTH AND FATIGUE IN MDX MICE 63
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 63
Apoptosis and apoptosis-related proteins in thyroid myopathies 63
VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice 62
Pilot study of flavocoxid in ambulant DMD patients. 62
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 62
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life InventoryTM Neuromuscular Module in the Italian population and correlation with other functional assessments. 62
Nusinersen versus sham control in later-onset spinal muscular atrophy 62
Pilot study of serial casting of ankles in muscular dystrophy patients. 61
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 59
A comprehensive molecular approach in COLA6 related myopathies based on genomic sequencing, transcriptional analysis and array CGH. 58
Methods of treating Duchenne muscular dystrophy with flavonoids 58
Genomic Variations Affecting Biological Effects of Statins 58
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 58
Autonomic nervous system involvement in spinal muscular atrophy. 58
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 58
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 58
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. 57
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 57
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 57
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 57
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 57
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 57
Dystrophin gene and SHOX gene mutations in a child with Becker muscular dystrophy and short stature 56
Daily salbutamol in young patients with SMA type II. 56
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 56
ANT1 is reduced in sporadic inclusion body myositis. 56
Congenital form of distal spinal muscular atrophy affecting the lower limbs: a common condition in childhood. 55
Impaired myocardial deformation revealing subclinical left ventricular dysfunction in children with Duchenne dystrophy: a speckle tracking echocardiography study 55
Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations 54
Prevalence of congenital muscular dystrophy in Italy: a population study 54
Severe rhabdomyolysis in a patient with “Heat Stroke” 54
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 54
Protocollo diagnostico e terapia delle patologie neuromuscolari ereditarie in età evolutiva 54
Axial myopathy in myasthenia: a misleading cause of dropped head 53
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 53
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes 53
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 53
Trattamento chirurgico delle scoliosi in pazienti affetti da distrofia muscolare di Duchenne. 52
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 52
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care? 52
Development of an academic disease registry for spinal muscular atrophy 52
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 52
Alexithymia, burden and resilience in ALS’ caregivers 52
Pilot study of flavocoxid in ambulant DMD patients. 52
Effect of treatment with PDTC and IRFI 042 on strenght and fatigue in mdx mice 51
North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. 51
Seizure aggravation caused by antiepileptic drugs in a patient with muscle-eye-brain disease. 51
Dual-echo dual flip angle gradient-echo MRI technique for quantification of muscle fat fraction in Duchenne muscular dystrophy: a new valuable outcome measure. 51
Factors predicting survival in ALS: a multicenter Italian study 51
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle 51
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 51
POMT2 mutation in a patient with 'MEB-like' phenotype. 50
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx. 50
Conceptualizing the relations between metacognition and executive functions in Amyotrophic Lateral Sclerosis (ALS) patients’ caregivers. A preliminary study 50
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 50
Caratterizzazione molecolare nelle miopatie da COLA6 mediante sequenziamento estensivo, analisi trascrizionale ed array CGH. 49
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone 49
Nuovi meccanismi nelle distrofie muscolari: i difetti di glicosilazione dell’ α-distroglicano. 49
Congenital muscular dystrophies with cognitive impairment. A population study. 49
6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes 49
Old measures and new scores in spinal muscular atrophy patients 49
Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy 49
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy 49
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 49
Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene. 48
Totale 6.251
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.536 0 0 0 0 0 205 198 189 72 399 377 96
2020/20211.874 152 63 411 88 327 128 91 165 53 200 106 90
2021/20221.696 9 123 13 113 97 14 126 72 51 119 211 748
2022/20234.412 392 321 161 311 381 388 29 237 2.010 21 122 39
2023/20241.118 84 202 73 101 115 216 48 31 16 43 28 161
2024/20251.021 98 76 102 352 246 147 0 0 0 0 0 0
Totale 13.559